CERTARA INC. - COMMON STOCK
10.64
10-January-25 10:17:38
15 minutes delayed
Stocks
-0.38
-3.45%
Today's range
10.58 - 10.86
ISIN
N/A
Source
NASDAQ
-
Certara Reports Fourth Quarter and Full Year 2021 Financial Results
01 Mar 2022 16:15:00 By Nasdaq GlobeNewswire
-
U.S. FDA Licenses Certara’s Immunogenicity Simulator
23 Feb 2022 16:30:00 By Nasdaq GlobeNewswire
-
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 8th Consecutive Year
15 Feb 2022 16:30:00 By Nasdaq GlobeNewswire
-
Certara to Report Fourth Quarter and Full Year 2021 Financial Results on March 1st, 2022
08 Feb 2022 16:30:00 By Nasdaq GlobeNewswire
-
21 Dec 2021 08:00:01 By Nasdaq GlobeNewswire
-
Certara Announces Release of Pinnacle 21 Enterprise Software
13 Dec 2021 08:00:01 By Nasdaq GlobeNewswire
-
Certara to Host Investor Day on December 15, 2021
08 Dec 2021 17:00:00 By Nasdaq GlobeNewswire
-
02 Dec 2021 08:00:01 By Nasdaq GlobeNewswire
-
Certara Announces Update of D360™ Scientific Informatics Software
29 Nov 2021 16:30:00 By Nasdaq GlobeNewswire
-
Certara Announces Closing of Public Offering of Common Stock
22 Nov 2021 17:45:00 By Nasdaq GlobeNewswire
-
Certara Announces Pricing of Public Offering of Common Stock
17 Nov 2021 23:27:02 By Nasdaq GlobeNewswire
-
Certara Announces Proposed Public Offering of Common Stock
15 Nov 2021 17:30:00 By Nasdaq GlobeNewswire
-
Certara Reports Third Quarter 2021 Financial Results
09 Nov 2021 16:10:00 By Nasdaq GlobeNewswire
-
Certara Appoints James E. Cashman III as Chairman of Board of Directors
08 Nov 2021 16:30:00 By Nasdaq GlobeNewswire
-
Certara to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference
03 Nov 2021 08:00:00 By Nasdaq GlobeNewswire
-
Pinnacle 21 Awarded FDA Contract for 5 Years for Software and Services
28 Oct 2021 08:00:01 By Nasdaq GlobeNewswire
-
Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award
25 Oct 2021 16:30:00 By Nasdaq GlobeNewswire
-
Certara to Report Third Quarter 2021 Financial Results on November 9th, 2021
19 Oct 2021 08:00:02 By Nasdaq GlobeNewswire
-
Certara Appoints Patrick F. Smith to President of Integrated Drug Development
12 Oct 2021 08:00:02 By Nasdaq GlobeNewswire
-
Certara Appoints Drayton T. Virkler as Chief Commercial Officer
05 Oct 2021 08:00:02 By Nasdaq GlobeNewswire